Live from the NIH registry
Studies recruiting near Wichita right now
Top 25 of 162 recruiting studies, sorted by proximity — each links to its official registry page
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Alliance for Multispecialty Research - Wichita East — Wichita, Kansas (0.4 mi)
· Sponsor: Sparrow Pharmaceuticals
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Kansas Nephrology Research Institute, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Boehringer Ingelheim
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Newly Diagnosed Multiple Myeloma
Phase 3
Interventional 750 participants sought
Research Site — Wichita, Kansas (0.4 mi)
· Sponsor: AstraZeneca
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Heart Failure, Cardiorenal Syndrome
N/A
Interventional 320 participants sought
Ascension via Christi Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Procyrion
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Janssen Research & Development, LLC
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Wichita, Kansas (0.4 mi)
· Sponsor: AstraZeneca
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Paradigm Health
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Kansas Gastroenterology, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Janssen Research & Development, LLC
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
Phase 3
Interventional 852 participants sought
IDC Clinical Research, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Vedanta Biosciences, Inc.
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Newton, Kansas (24.7 mi)
· Sponsor: Kailera
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Wichita, Kansas (0.4 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
West Houston Area Clinical Trial Consultants, LLC - Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: Boehringer Ingelheim
PCOM2 - The Physician Communication Intervention, Version 2.0
HPV Infection, Preventive Health Services
N/A
Interventional 120 participants sought
University of Kansas Medical Center — Wichita, Kansas (0.4 mi)
· Sponsor: University of Colorado, Denver
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Kansas Gastroenterology, LLC under Clinical Trials Network — Wichita, Kansas (0.4 mi)
· Sponsor: Hoffmann-La Roche
Virtue® SAB in the Treatment of Coronary ISR Trial
Coronary Artery Disease
N/A
Interventional 740 participants sought
Ascension Via Christi Saint Francis — Wichita, Kansas (0.4 mi)
· Sponsor: Orchestra BioMed, Inc
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
Phase 3
Interventional 1,059 participants sought
Alliance For Multispeciality Research - Wichita East /ID# 234126 — Wichita, Kansas (0.4 mi)
· Sponsor: AbbVie
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Type II Diabetes Mellitus
Phase 2
Interventional 285 participants sought
AMR Clinical - Newton — Newton, Kansas (24.7 mi)
· Sponsor: Sun Pharmaceutical Industries Limited
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 2
Interventional 300 participants sought
AMR Clinical - El Dorado — El Dorado, Kansas (27.8 mi)
· Sponsor: Housey Healthcare ULC
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Refractory Angina
N/A
Interventional 380 participants sought
Cardiovascular Research Institute of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Shockwave Medical, Inc.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Kansas Nephrology Physicians, PA — Wichita, Kansas (0.4 mi)
· Sponsor: CSL Behring
Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
Overactive Bladder, Overactive Bladder (OAB)
N/A
Interventional 202 participants sought
Cypress Medical Research Center — Wichita, Kansas (0.4 mi)
· Sponsor: InMode MD Ltd.
Pridopidine Phase 3 Study in Huntington's Disease
Huntington Disease
Phase 3
Interventional 400 participants sought
Hereditary Neurological Disease Centre — Wichita, Kansas (0.4 mi)
· Sponsor: Prilenia
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
Cancer Center of Kansas-Wichita Medical Arts Tower — Wichita, Kansas (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Phase 3
Interventional 700 participants sought
Cancer Center of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Janssen Research & Development, LLC